Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 50

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 50
---
 contemplated in Section 5.8;                                                                |

| (X) | not acquire or agree to acquire (by merger, amalgamation, arrangement, acquisition of stock or assets or                                                                                                                                                 
 otherwise) any person or division of any person or make any investment either by purchase of shares or securities, contributions of capital (other than to the Subsidiary), property transfer or purchase of any property or assets of any other person; |

| (Y) | except in connection with the Discontinuance, not adopt a plan of complete or partial liquidation, arrangement,                                                                                                                                      
 dissolution, amalgamation, merger, consolidation, restructuring, recapitalization, winding-up or other reorganization of the Company or the Subsidiary (other than this Agreement and the Contemplated                                               
 Transactions), or file a petition in bankruptcy under any applicable Law on behalf of the Company or the Subsidiary, or consent to the filing of any bankruptcy petition against the Company or the Subsidiary under any applicable Law; for further 
 certainty, nothing in this Agreement shall limit the ability of the Company to liquidate, wind-up and/or dissolve the Subsidiary during the Interim Period;                                                                                          |

| (AA) | not (1) make, change or revoke any material Tax election, (2) change any annual Tax accounting                                                                                                                                       
 period, (3) adopt or make any material change to any material method of Tax accounting, (4) amend any material Tax Return in a manner prejudicial to the Company, (5) surrender any claim for a material refund of Taxes, (6) except 
 in respect of the ongoing audits disclosed in Schedule 18(f) of the Disclosure Letter, settle or                                                                                                                                     |

- 27 -

| compromise any material claim, assessment or other dispute in respect of Taxes, (7) enter into or make any voluntary disclosure with respect to any material amount of Taxes, (8) enter                                                                  
 into any Tax sharing, allocation, indemnification, receivable reimbursement, or similar agreement (whether or not written), (9) fail to pay any material Tax as such Tax became due and payable (including any estimated Tax), (10) prepare and file any 
 Tax Return in a manner materially inconsistent with past practice, or (11) incur any material liability for Taxes outside the Discontinuance;                                                                                                            |

| (BB) | except as contemplated in Section 6.1, (I) not enter into any transaction or perform any act, and